The Star·1 min read·medium
Big Smile, No Teeth: Here’s a Faustian deal for you
✦AI Summary
Recent clinical trials suggest that semaglutide, the active ingredient in Ozempic, may have the secondary effect of slowing biological ageing markers. This discovery marks a potential shift in the medical understanding of the drug's capabilities.
WE’RE on the road to living longer! Scientists announced this week that semaglutide, the active ingredient in Ozempic, may slow biological ageing. Researchers found it reduced ageing markers in clinical trials, marking the first evidence that the dru... [3959 chars]
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in